Table 1 Clinical characteristics of the study cohort.
Total (n = 12,326) | Quartiles of AIP | P | ||||
|---|---|---|---|---|---|---|
I (lowest) (n = 3103) 0.620 − 0.170 | II (n = 3064) 0.171 − 0.369 | III (n = 3085) 0.370 − 0.575 | IV (highest) (n = 3074) 0.576 − 1.738 | |||
Age, years | 51.7 ± 8.5 | 51.6 ± 9.0 | 52.1 ± 8.6 | 52.2 ± 8.4 | 50.9 ± 7.9 | < 0.001 |
Male, n (%) | 10,382 (84.2) | 2,134 (68.8) | 2,573 (84.0) | 2,793 (90.5) | 2,882 (93.8) | < 0.001 |
Systolic BP, mmHg | 119.6 ± 15.0 | 117.5 ± 15.1 | 119.5 ± 15.1 | 120.1 ± 15.0 | 121.1 ± 14.6 | < 0.001 |
Diastolic BP, mmHg | 75.0 ± 10.5 | 72.9 ± 10.7 | 75.0 ± 10.5 | 75.5 ± 10.4 | 76.8 ± 10.2 | < 0.001 |
BMI, kg/m2 | 24.6 ± 2.8 | 23.3 ± 2.7 | 24.3 ± 2.6 | 25.0 ± 2.6 | 25.7 ± 2.6 | < 0.001 |
Traditional risk factors | ||||||
Hypertension, n (%) | 4,016 (33.6) | 806 (27.0) | 965 (32.6) | 1,095 (36.6) | 1,150 (38.3) | < 0.001 |
Diabetes, n (%) | 1,703 (13.8) | 300 (9.7) | 367 (12.0) | 502 (16.3) | 534 (17.4) | < 0.001 |
Hyperlipidemia, n (%) | 3,455 (28.0) | 587 (18.9) | 767 (25.0) | 926 (30.0) | 1,175 (38.2) | < 0.001 |
Obesity, n (%) | 5,178 (42.2) | 760 (24.6) | 1,153 (37.8) | 1,468 (47.8) | 1,797 (58.6) | < 0.001 |
Current smoking, n (%) | 3,229 (28.5) | 529 (18.6) | 669 (23.9) | 891 (31.4) | 1,140 (40.1) | < 0.001 |
Laboratory | ||||||
Total cholesterol, mg/dL | 197.5 ± 34.0 | 191.9 ± 32.1 | 195.5 ± 33.6 | 198.0 ± 34.0 | 204.6 ± 35.1 | < 0.001 |
Triglyceride, mg/dL | 141.7 ± 89.4 | 69.9 ± 19.9 | 103.2 ± 21.9 | 143.1 ± 29.7 | 250.9 ± 108.1 | < 0.001 |
HDL-C, mg/dL | 53.3 ± 16.0 | 68.3 ± 19.3 | 54.7 ± 10.9 | 48.5 ± 9.0 | 41.8 ± 7.7 | < 0.001 |
LDL-C, mg/dL | 122.0 ± 31.7 | 110.2 ± 30.8 | 123.8 ± 31.0 | 128.0 ± 30.5 | 126.1 ± 31.5 | < 0.001 |
Fasting glucose, mg/dL | 97.8 ± 20.3 | 92.9 ± 16.3 | 96.6 ± 17.8 | 99.4 ± 20.7 | 102.3 ± 24.4 | < 0.001 |
HbA1C, % | 5.7 ± 0.7 | 5.5 ± 0.6 | 5.6 ± 0.7 | 5.7 ± 0.8 | 5.8 ± 0.9 | < 0.001 |
AIP | 0.377 ± 0.295 | 0.007 ± 0.129 | 0.274 ± 0.057 | 0.469 ± 0.058 | 0.759 ± 0.154 | < 0.001 |
